Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step

Infections account for significant morbidity and mortality in liver cirrhosis and most are related to the gut microbiome. Fecal dysbiosis, characterized by an overgrowth of potentially pathogenic bacteria and a decrease in autochthonous non-pathogenic bacteria, becomes prominent with the progression...

Descripción completa

Detalles Bibliográficos
Autor principal: Fukui, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606971/
https://www.ncbi.nlm.nih.gov/pubmed/28936406
http://dx.doi.org/10.14218/JCTH.2017.00008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606971/
https://www.ncbi.nlm.nih.gov/pubmed/28936406
http://dx.doi.org/10.14218/JCTH.2017.00008

Ejemplares similares